Faropenem is a novel oral carbapenem antibiotic belonging to the penem group. It is a broader-spectrum antibiotic that is 4-8 times more active against methicillin-susceptible Staphylococcus aureus (MSSA) compared to other commonly used antibiotics. Faropenem offers a significant advantage over other parenteral carbapenems, as it is available in an oral form, making it more convenient…
Know More
Faroeze is an orally active beta-lactam antibiotic belonging to the penem group. Faroeze is a new oral penem which shows broad antibacterial activity against both aerobic and anaerobic gram positive and gram-negative bacteria. Faroeze is bactericidal, with a strong affinity for the high molecular penicillin binding proteins (PBPs) of the cell wall, which is essential…
Know More
FCMalt (Ferric carboxymaltose) is a parenteral, dextran-free iron formulation designed to overcome the limitations of existing intravenous (IV) injections. It is a safe, well tolerated and stable complex, associated with improvements in hemoglobin. Due to the stability of the complex, it does not release ionic iron under physiological conditions.
Know More
Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor indicated for managing diabetes mellitus type 2. When combined with diet and exercise in adults, dapagliflozin helps to improve glycemic control by inhibiting glucose resorption in the proximal tubule of the nephron and causing glycosuria. Dapagliflozin was approved by the FDA on Jan 08, 2014. Metformin is a…
Know More
Drug class: Narrow-spectrum beta-lactam antibiotic of the penicillin class Flucloxacillin is used to treat a wide variety of infections like Skin and soft tissue infection, Endocarditis, Pneumonia, Osteomyelitis, chest and wound infections. It diffuses well into most tissues & organs. Effective against infections caused by methicillin-susceptible S. aureus (MSSA). Resistant to penicillinase enzyme. Flucloxacillin should…
Know More
Fosdown is an advanced, iron-based, calcium-free phosphate binder formulated for the control of serum phosphorus in adults with chronic kidney disease (CKD) undergoing dialysis. Its unique mechanism of action allows it to effectively reduce dietary phosphate absorption by binding phosphate in the gastrointestinal (GI) tract, forming insoluble complexes that are excreted in the feces. By…
Know More
